Results 191 to 200 of about 79,696 (205)

Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction

Sexual Medicine Reviews, 2018
Faysal A Yafi
exaly  

Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome

Circulation, 2006
Saibal Mukhopadhyay, Sanjay Tyagi
exaly  

Use of Phosphodiesterase Type 5 Inhibitors May Adversely Impact Biochemical Recurrence after Radical Prostatectomy

Journal of Urology, 2015
Thorsten Schlomm, Pierre Tennstedt, Burkhard Beyer   +2 more
exaly  

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh   +2 more
exaly  

Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential

Bioorganic and Medicinal Chemistry, 2016
Nariman F Salakhutdinov
exaly  

Phosphodiesterase 5 inhibitors: current status and potential applications

Nature Reviews Drug Discovery, 2002
exaly  

EVIDENCE FOR CONTAMINATION OF HERBAL ERECTILE DYSFUNCTION PRODUCTS WITH PHOSPHODIESTERASE TYPE 5 INHIBITORS

Journal of Urology, 2005
Neil Fleshner
exaly  

Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease

Lancet, The, 2005
exaly  

Nitrates and Phosphodiesterase-5 Inhibitors

Journal of the American College of Cardiology
Dimitrios Terentes-Printzios, Stergios Soulaidopoulos, Nikolaos Ioakeimidis, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
openaire   +1 more source

DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN

Lancet, The, 1978
exaly